Home
About
Overview
Sharing Data
ORCID
Help
History (9)
Rotarod Performance Test
Blood Glucose Self-Monitoring
Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor.
Inhibition of MET receptor tyrosine kinase and its ligand hepatocyte growth factor. J Thorac Oncol. 2012 Dec; 7(16 Suppl 5):S372-4.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials as Topic
Hepatocyte Growth Factor
Humans
Molecular Targeted Therapy
Neoplasms
Protein Binding
Proto-Oncogene Proteins c-met
authors with profiles
Ravi Salgia